Sfoglia per Dipartimento 100007 - Dipartimento di Medicina interna e specialità mediche
Development and testing of anti-eNAMPT neutralizing monoclonal antibodies
2023
Development of new, potent NAPRT inhibitors by CADD
2022
Disruption of DNA damage response pathways in tumorigenesis: investigating the role of ATM and BAP1 in hereditary cancers.
2020
EARLY HEPATIC RECURRENCE AFTER COLORECTAL CANCER LIVER METASTASES SURGERY: A SINGLE PROSPECTIVE CENTRE STUDY
2020
Effectiveness and safety of biologics in pediatric inflammatory bowel disease: Real-life data from the Sicilian Network
2023
ENDOTHELIAL SIRT6 BLUNTS STROKE SIZE AND NEUROLOGICAL DEFICIT BY PRESERVING BLOOD-BRAIN BARRIER INTEGRITY: A TRANSLATIONAL STUDY
2021
EORTC-SPECTA Arcagen study, comprehensive genomic profiling and treatment adaptation of rare thoracic cancers
2024
Evidence for a pro-oncogenic role of Sirtuin 6 in breast tumorigenesis
2019
Feasibility study of intraoperative surgical navigation with focus on ureteral identification using the EVA system on an animal model.
2024
FENOTIPO E GENOTIPO DELLA PERCEZIONE GUSTATIVA, STATO NUTRIZIONALE E COMPOSIZIONE CORPOREA DI ANZIANI OSPITI DI RSA DON ORIONE GENOVA
2024
Fisiopatologia dei recettori della somatostatina nei tumori ipofisari GH-secernenti
2021
Genomic analysis of special types of invasive breast cancer
2021
GENOTYPE – PHENOTYPE CORRELATIONS IN CUTANEOUS MELANOMA PATIENTS CARRIER OF THE MITF p.E318K PATHOGENIC VARIANT
2019
GERIATRIC CO-MANAGED CARE OF OLDER ADULTS ADMITTED TO A SURGICAL SERVICE FOR GASTROINTESTINAL CANCER. A PROPENSITY SCORE ANALYSIS
2021
Gestione dell’acromegalia in un centro di riferimento: valutazione dei costi diretti di malattia e gestione del paziente durante la pandemia da SARS-CoV-2
2022
Hepatocellular adenoma classification using MRI and identification of biomarkers for prediction of liver tumor onset in a mouse model of glycogen storage disease type1a.
2019
Identification of a Midnolin-proteasome pathway impacting Multiple Myeloma cell growth
2025
IDENTIFICATION OF NOVEL BIGUANIDE BASEDCOMPOUNDS AS ANTI TUMOR AGENTS FOR GLIOBLASTOMA: PHARMACOLOGICAL ASSESSMENT IN 3D CULTURE MODELS
2022
Identification of prognostic and predictive liquid biopsy biomarkers in patients with Cutaneous Squamous Cell Carcinoma (CSCC) treated with Cemiplimab.
2025
IL METABOLISMO CARDIACO ESPLORABILE IN VIVO CON FDG-PET È UN POTENZIALE MARCATORE DI CARDIOTOSSICITÀ DA ANTRACICLINE STUDIO SPERIMENTALE E CLINICO IN MODELLO MURINO E IN PAZIENTI CON LINFOMA DI HODGKIN
2019
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile